Genmab — April 2018
-
Nej, du SH tallene er 5-10% for høje, og det har Sydbank korrigeret for
-
Et bud på en eksponentiel udvikling af dara salgstal for 2018 http://www.proinvestor.com/?p=debat_1&postid=76077&thread=50&start=
-
Aktieugebrevet har sælg på Genmab, med bemærkningen "åbner op for en korrektion på 10-15% ned til 1030". Hvad siger I til det, det kommer vel også an på tallene i ugen fra J&J, hvis de overrasker positivt, kan vi vel hurtigt vende snuden opad istedet ? Kommentarer ?
-
God morgen.

-
-
God morgen

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
